Skip to content

Drug interactions

Empagliflozin-metformin + Ondansetron

Severity: Minor

Empagliflozin-metformin and Ondansetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ondansetron may raise metformin exposure by interfering with renal tubular secretion, though the clinical significance is modest. Increased metformin levels could add to gastrointestinal effects and, in susceptible patients, lactic acidosis risk.

What this interaction means in plain words

Empagliflozin-metformin and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Empagliflozin-metformin belongs to Endocrine; Ondansetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Inhibition of renal organic cation transporters and MATE proteins reduces metformin tubular secretion.

What to do

No dose change is usually needed; monitor glucose and renal function in patients with impaired kidney function.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-metformin and Ondansetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin-metformin with Ondansetron?

MediHelp rates the interaction as minor. Empagliflozin-metformin and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ondansetron may raise metformin exposure by interfering with renal tubular secretion, though the clinical significance is modest. Increased metformin levels could add to gastrointestinal effects and, in susceptible patients, lactic acidosis risk.

How serious is the interaction between Empagliflozin-metformin and Ondansetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed; monitor glucose and renal function in patients with impaired kidney function.

What other medicines interact with Empagliflozin-metformin?

MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in